JG
CAI

Joel Greenblatt’s Caris Life Sciences CAI Stock Holding History

Joel Greenblatt’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
89,535
-654,891
-88% -$11.7M ﹤0.01% 1222
2026
Q1 		$13.3M Buy
744,426
+677,240
+1,008% +$14.8M 0.04% 606
2025
Q4 		$1.81M Buy
67,186
+33,983
+102% +$957K 0.01% 1067
2025
Q3 		$1M Buy
+33,203
New +$1.06M ﹤0.01% 1199

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Joel Greenblatt's CAI Position: Q2 2026 in Review

Joel Greenblatt reduced its Caris Life Sciences (CAI) stake by 88% in Q2 2026, selling an estimated $11.7M and leaving 89,535 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Joel Greenblatt first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.3M in Q1 2026. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Joel Greenblatt held 89,535 shares of Caris Life Sciences worth $1.6M as of Q2 2026.
  • Joel Greenblatt sold 654,891 Caris Life Sciences shares in Q2 2026, an estimated $11.7M.
  • Caris Life Sciences made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1222 holding.
  • Joel Greenblatt first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Joel Greenblatt's Caris Life Sciences position peaked at $13.3M in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.